Abstract <p>This review provides a comprehensive overview of the latest advancements made in PET radiotracers based on low-molecular-mass inhibitors of fibroblast (major component of tumor microenvironment) activation protein (FAPIs). Two approaches to the synthesis of the radiotracers based on an effective FAPI, <i>N</i>-(4-quinolinoyl)-glycyl-2-cyanopyrrolidine (UAMC1110), are discussed. The first approach is “pseudo-chelation” of fluorine-18 in the form of the [<sup>18</sup>F]AlF<sup>2+</sup> cation by NOTA chelator. The second approach is based on classical methods for preparing FAPI radiotracers with <sup>18</sup>F–C covalent bond by aliphatic nucleophilic substitution, copper-catalyzed radiofluorination of nonactivated arenes, indirect label introduction into a linker-modified UAMC1110 molecule using various radio synthons, etc. Special attention is paid to the characteristics of the new FAPI agents with the <sup>18</sup>F–C covalent bond, such as affinity for FAP, selectivity, lipophilicity, and tumor uptake, which determine their potential application in cancer diagnostics.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Small Molecules Labeled with Fluorine-18 as Inhibitors of Fibroblast Activation Protein (FAP) for PET Imaging of Tumors

  • O. S. Fedorova,
  • R. N. Krasikova

摘要

Abstract

This review provides a comprehensive overview of the latest advancements made in PET radiotracers based on low-molecular-mass inhibitors of fibroblast (major component of tumor microenvironment) activation protein (FAPIs). Two approaches to the synthesis of the radiotracers based on an effective FAPI, N-(4-quinolinoyl)-glycyl-2-cyanopyrrolidine (UAMC1110), are discussed. The first approach is “pseudo-chelation” of fluorine-18 in the form of the [18F]AlF2+ cation by NOTA chelator. The second approach is based on classical methods for preparing FAPI radiotracers with 18F–C covalent bond by aliphatic nucleophilic substitution, copper-catalyzed radiofluorination of nonactivated arenes, indirect label introduction into a linker-modified UAMC1110 molecule using various radio synthons, etc. Special attention is paid to the characteristics of the new FAPI agents with the 18F–C covalent bond, such as affinity for FAP, selectivity, lipophilicity, and tumor uptake, which determine their potential application in cancer diagnostics.